Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study

PURPOSE: We hypothesized that granulocyte-macrophage colony-stimulating factor (GM-CSF) could potentiate the clinical activity of rituximab, given their individual and cooperative effects on FcγRIIa- and FcγRIIIa-expressing cells. A phase II clinical study combining GM-CSF and rituximab was initiate...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Cartron, Guillaume, Zhao-Yang, Lu, Baudard, Marion, Kanouni, Tarik, Rouillé, Valérie, Quittet, Philippe, Klein, Bernard, Rossi, Jean-Francois
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2008
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2443403/
https://ncbi.nlm.nih.gov/pubmed/18427151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.7729
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker